Biotech

All Articles

' Scientific instinct' led FDA experts to back Zevra's uncommon health condition med

.Zevra Therapies' rare health condition drug appears to be on the path to authorization this loss af...

Pfizer takes $230M attacked after axing stopped working DMD genetics therapy

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics therapy failing has actually blown a $2...

AC Immune observes 'site' possible in Alzheimer's medicine records

.After much more than twenty years of deal with neurodegenerative diseases, Swiss biotech hvac Immun...

GSK goes down ph. 2 HPV vaccination over absence of best-in-class prospective

.GSK has ditched a stage 2 human papillomavirus (HPV) injection coming from its own pipeline after d...

OS Treatments refiles $6M IPO to money HER2 medication, preclinical ADCs

.OS Therapies will definitely provide on the NYSE American supply swap today through a $6.4 thousand...

ALX's fizzling CD47 action cost sends out stock spiraling down

.ALX Oncology's period 2 stomach cancer feedback rate has actually compromised. After seeing its own...

Ionis centers eye health condition from aim ats of Roche-partnered prospect after data let down

.Another of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of assumptions, trigge...

Biogen's CEO said no high-risk deals in 2023. He prepares to be vibrant

.While Biogen's pharma peers are actually seeking for late-stage assets along with little risk, chie...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Bio has been actually a biotech seeking a pipeline after it scrapped its lead possessions ov...

Biogen walks away from Denali Alzheimer's collab

.Biogen has restored civil rights to a very early Alzheimer's disease plan to Denali Therapeutics, g...